Peak ATP + enfinity: Synergizing Stimulant and Stimulant-Free Ingredients

enfinity + Peak ATP

The unique synergy between Peak ATP and enfinity, designed to enhance physical and cognitive performance.

At PricePlow, we’ve been covering Peak ATP for years, discovering that it does more than just provide energy. Peak ATP supports blood flow, enhances muscular excitability, and aids in post-exercise cognition. Its benefits extend beyond traditional stimulant-free energy supplements, making it a staple for athletes and fitness enthusiasts.

enfinity paraxanthine, on the other hand, is a newer player in the supplement world, gaining recognition as a caffeine alternative. Like caffeine, this stimulant sharpens focus as it boosts energy levels, but it offers more benefits with fewer side effects.

Recent research shows that enfinity increases energy expenditure while reducing heart rate and hunger. Another study demonstrated that it outperforms caffeine in post-exercise cognitive tests. These findings position enfinity as a powerful, multifaceted performance-enhancement ingredient.

Paraxanthine Outforms Caffeine

A new study finds paraxanthine (found in enfinity®) outperforms caffeine in boosting cognitive function after a 10k run.[1] Clear thinking under pressure is key to winning, and paraxanthine could be the edge you need.

Previously, we explored the synergy between Peak ATP and creatine, showcasing how these two ingredients work together to amplify physical performance. Now, we shift our focus to another promising combination: Peak ATP and enfinity paraxanthine.

Peak ATP + enfinity: Optimizing Performance and Energy

In this article, we delve into the unique synergy between these two ingredients, exploring how their combined effects can elevate both physical and cognitive performance. By harnessing the distinct advantages of each ingredient, we aim to uncover the full potential of this powerful duo and offer ideas for safely formulating and supplementing them together.

Before getting started, sign up for our TSI Group news alerts to stay informed. TSI is the exclusive distributor of both ingredients and has compiled an impressive body of research on both:

Subscribe to PricePlow's Newsletter and Alerts on These Topics

Topic Blog Posts YouTube Videos Instagram Posts
Peak ATP
TSI Group
enfinity

Understanding the Two Ingredients

Peak ATP

Peak ATP is a patented oral ATP supplement that’s been shown to increase blood flow, boost muscle activation through calcium release, and help boost muscle mass, strength, and recovery. This article covers the biochemistry, mechanism, and human research in detail.

Let’s examine each ingredient to briefly capture their roles in nutrition and performance:

What is Peak ATP?

ATP is short for adenosine triphosphate, and Peak ATP is a patented and trademarked disodium ATP ingredient.

The bonds in the ATP make it highly-charged, serving as an energy carrier in the body. Some researchers call it “life’s energy reservoir”.[2] This is why it’s dubbed the “energy currency” of our cells — it’s found in every cell in the human body.[3]

Given ATP’s broad-ranging impact on cellular energy, Peak ATP has been successfully used for numerous purposes beyond just energy. A research review published in 2021 summarized the findings as follows:[4]

The available literature on ATP disodium when provided in a dose of at least 400 mg approximately 30 min before a workout or 20–30 min before breakfast on non-exercise days provides insight into its potential to reduce fatigue (Purpura et al., 2017,[5] Rathmacher et al., 2012[6]), increase strength and power (Wilson et al., 2013[7]), improve body composition (Hirsch et al., 2017[8], Wilson et al., 2013[7]), maintain muscle health during stress (Long and Zhang, 2014,[9] Wilson et al., 2013[7]), increase recovery and reduce pain (de Freitas et al., 2018[10], Khakh and Burnstock, 2009,[3] Wilson et al., 2013[7]). Additionally, other literature indicates a role for ATP in improving cardiovascular health (Hirsch et al., 2017,[8] Ju et al., 2016,[11] Rossignol et al., 2005[12]).[4]

Peak ATP Post Exercise Cognitive Performance

Exercise can create a feeling of mental fatigue by eliciting deficits in attention and processing speed. A study published in 2023 showed that PEAK ATP® helps mitigate deficits in several cognitive tasks following exercise.[11]

Earlier research also showed significantly increased blood flow following exercise with the use of this novel ingredient.[13]

Since then, additional research has supported Peak ATP’s ability to mitigate cognitive decline after strenuous exercise.[11] A meta-analysis published in 2024 concluded that 400 milligrams of disodium ATP supplementation enables users to achieve significantly greater gains in maximal strength compared to placebo.[12]

Given the extensive research, Peak ATP should always be considered alongside industry mainstays like betaine, creatine, and HMB when formulating muscle-building and performance-based supplement stacks.

Readers can see our full Peak ATP breakdown for more details, but that’s only half of today’s equation. With enfinity, we can enhance Peak ATP’s stimulant-free power to further boost athletic performance.

What is enfinity?

enfinity is the trademarked name of paraxanthine, the stimulatory ingredient that serves as a caffeine replacement.

Paraxanthine: Sold as enfinity and Distributed by TSI Group

Paraxanthine is the primary metabolite of caffeine, providing most of caffeine’s beneficial effects. Now you can take it directly with enfinity!

Paraxanthine is actually the primary metabolite of caffeine, and both function similarly by antagonizing adenosine receptors to promote wakefulness. When you ingest caffeine, roughly 70-80% of it metabolizes into paraxanthine.[14-16] However, two other metabolites, theophylline and theobromine, which have far longer half-lives (~6.2 and 7.2 hours,[14] respectively) and more severe side effect profiles.

Avoiding the pitfalls of caffeine’s other metabolites

By side-stepping the two longer-lasting metabolites with paraxanthine, users get the desired effects of caffeine without the drawbacks. Its half-life is 3.1 hours,[14] providing a better-targeted energy solution that doesn’t leave theophylline and theobromine circulating in the body into the night.

However, reported half-lives are just the average: Not everyone metabolizes caffeine the same way. There are slow, medium, and fast metabolizers, depending on one’s genetics.[17] The situation with caffeine and its other metabolites is even more challenging for slow metabolizers.[18,19] With 46% of the population being fast metabolizers, that means 54% are either slow or intermediate metabolizers![20]

Paraxanthine does it better

Beyond the shorter half-life, paraxanthine has four other major benefits:

Caffeine Metabolism: Paraxanthine, Theophylline, and Theobromine

Caffeine has three major metabolites, and one of them (paraxanthine) does the heavy lifting. The other two have very long half-lives, which could be interfering with your experience. Image courtesy TSI Group

  1. Several genes control the breakdown of paraxanthine, while caffeine is only handled by two — and only one (CYP1A2) controls its breakdown into paraxanthine.[21,22] See the image inset to the right.
  2. Paraxanthine has higher binding potency for adenosine A1 and A2a receptors.[23,24]
  3. Paraxanthine can potentiate nitric oxide (NO) signaling through PDE9 inhibition,[25,26] while caffeine cannot.[26]
  4. Paraxanthine supports dopamine production[25,26] and has been shown to protect dopaminergic neurons.[27]

This translates to better efficacy with greater consistency across individuals.

Now let’s take a closer look at how these ingredients can work together.

The Synergistic Benefits of Peak ATP and enfinity

Aside from their shared benefits, there are several ways these two ingredients can work together synergistically:

Adenosine Receptor Antagonism and ATP Supplementation

Cognitive Flexibility

Image courtesy Dr. Ralf Jäger

Paraxanthine acts as an adenosine receptor antagonist, reducing the inhibitory effects of adenosine on neurotransmitter release.[28] This supports increased alertness, reduced fatigue, and enhanced cognitive and physical performance.[29]

Exogenous ATP provides a direct source of cellular energy, supporting various functions, including those in the brain and muscles. ATP can be broken down into adenosine, which plays a role in cellular signaling. This breakdown can be modulated by paraxanthine’s action on adenosine receptors, balancing adenosine’s effects in different tissues.

By using them together, we can supply the body with more energy from Peak ATP while using paraxanthine to limit the effects of its breakdown into adenosine.

Enhanced Fatty Acid Oxidation and Immediate Energy Supply

Paraxanthine increases lipolysis and enhances fatty acid oxidation,[30] providing a sustained energy supply from fat stores and increasing energy expenditure (up to 100 calories in 3 hours).[31] This helps maintain energy levels during prolonged physical activities.

Peak ATP offers an immediate source of energy that can be rapidly utilized by cells. This quick energy supply complements the sustained energy from fatty acid oxidation, providing balanced energy availability.

Cognitive Enhancement Through Neurotransmitter Modulation

Cognitive Flexibility

Image courtesy Dr. Ralf Jäger

Paraxanthine enhances the release of neurotransmitters like dopamine and norepinephrine by antagonizing adenosine receptors.[23-27] This leads to improved mood, alertness, and cognitive function.[1,29]

Exogenous ATP supports synaptic function and neurotransmitter release by providing the necessary energy for these processes. Enhanced ATP levels can improve overall brain energy metabolism, complementing paraxanthine’s effects on neurotransmitter systems.

Both ingredients have been shown to support improved cognition after strenuous exercise.[11,31]

Anti-Inflammatory and Neuroprotective Effects

Paraxanthine possesses anti-inflammatory properties,[32] which can protect cells from stress and damage.

ATP plays a role in cellular signaling pathways that modulate inflammation and protect against cellular damage. One study showed that oral ATP supports muscle maintenance and recovery after surgery.[9]

Together, these ingredients can provide enhanced protection and recovery in tissues subjected to stress or injury.

Dosing and Formulation Strategies

enfinity paraxanthine is clinically-validated at 100-300 milligrams per serving, with a maximum of 400 milligrams per day. Peak ATP is clinically validated at 400 milligrams per day.

enfinity + Peak ATP Benefits

This means a brand could simply combine both into one capsule to create an incredible supplement with minimal effort.

However, we like to go further, so we’ll propose a basic pre-workout supplement with the following ingredients:

Peak ATP + enfinity Pre-Workout Idea

enfinity + Peak ATP Structure

  • Citrulline and/or Nitrosigine: 4g total or more
  • Beta-Alanine: 3.2g or more
  • Betaine Anhydrous: 2.5g or more
  • L-Tyrosine: 1-2g
  • Peak ATP: 400mg
  • enfinity: 200-300mg
  • Cognizin citicoline: 250mg
  • Sodium and Potassium

This is a simple yet effective supplement that covers numerous bases without any untested ingredients. The above could also be paired down to create a novel nootropic formula, something we’d love to see on the market.

Alternatively, we would love to see an “afternoon energy muscle builder” to combat the afternoon crash:

enfinity Paraxanthine Energy Expenditure Study

New research data has been published on enfinity (paraxanthine), showing increased energy expenditure compared to placebo (100 calories in 3 hours) — yet it decreased appetite and heart rate![31]

Peak ATP + enfinity Afternoon Energy Muscle Builder

  • Creatine Monohydrate: 3-5g
  • myHMB: 1.5-3g
  • Betaine Anhydrous: 2.5g
  • Peak ATP: 400mg
  • GG-Gold (Geranylgeraniol): 300mg
  • enfinity: 200mg
  • Potassium and Zinc
  • Niacin (as nicotinic acid): 20mg

No more afternoon slumps with this one — this covers several bases to give the body the tools it needs to keep growing. It could also be used in the morning as a coffee replacement.

Achieve Peak Energy and Performance

Peak ATP and Creatine

Peak ATP + Creatine make an epic, synergistic duo to boost ATP for improved cellular energy and muscular gains!

Just as we love Peak ATP with creatine, we’d be thrilled to see more well-formulated supplements that combine Peak ATP and enfinity. Their complementary mechanisms of action may enhance their overall effects on energy metabolism, cognitive function, and physical performance.

Paraxanthine’s ability to modulate adenosine receptors and enhance fatty acid oxidation complements the immediate energy supply and blood flow provided by exogenous ATP. This combination can lead to improved cellular energy homeostasis, enhanced neurotransmitter function, and better overall cellular protection and performance.

And that means maximizing both mental and physical performance.

Sign up for our TSI News alerts below:

Subscribe to PricePlow's Newsletter and Alerts on These Topics

Topic Blog Posts YouTube Videos Instagram Posts
Peak ATP
TSI Group
enfinity

About the Author: PricePlow Staff

PricePlow Staff

PricePlow is a team of supplement industry veterans that include medical students, competitive strength athletes, and scientific researchers who all became involved with dieting and supplements out of personal need.

The team's collective experiences and research target athletic performance and body composition goals, relying on low-toxicity meat-based diets.

No Comments | Posted in , , , | Tagged , , , , .

References

  1. Yoo, Choongsung et al. “Paraxanthine provides greater improvement in cognitive function than caffeine after performing a 10-km run.” Journal of the International Society of Sports Nutrition vol. 21,1 (2024): 2352779. doi:10.1080/15502783.2024.2352779. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11089923/
  2. Chu, Xin-Yi, et al. “The Legend of ATP: From Origin of Life to Precision Medicine.” Metabolites, vol. 12, no. 5, 20 May 2022, p. 461, doi:10.3390/metabo12050461. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148104/
  3. Khakh, Baljit S, and Geoffrey Burnstock. “The Double Life of ATP.” Scientific American, vol. 301, no. 6, 2009, pp. 84–90, 92; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877495/
  4. Jäger, Ralf, et al. “Health and Ergogenic Potential of Oral Adenosine-5′-Triphosphate (ATP) Supplementation.” Journal of Functional Foods, vol. 78, Mar. 2021, p. 104357, 10.1016/j.jff.2021.104357. https://www.sciencedirect.com/science/article/pii/S1756464621000062
  5. Purpura, Martin, et al. “Oral Adenosine-5′-Triphosphate (ATP) Administration Increases Postexercise ATP Levels, Muscle Excitability, and Athletic Performance Following a Repeated Sprint Bout.” Journal of the American College of Nutrition, vol. 36, no. 3, 1 Mar. 2017, pp. 177–183, 10.1080/07315724.2016.1246989; https://www.tandfonline.com/doi/full/10.1080/07315724.2016.1246989
  6. ‌Rathmacher, John A, et al. “Adenosine-5′-Triphosphate (ATP) Supplementation Improves Low Peak Muscle Torque and Torque Fatigue during Repeated High Intensity Exercise Sets.” Journal of the International Society of Sports Nutrition, vol. 9, 9 Oct. 2012, p. 48, 10.1186/1550-2783-9-48; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483284/
  7. Wilson, Jacob M et al. “Effects of oral adenosine-5′-triphosphate supplementation on athletic performance, skeletal muscle hypertrophy and recovery in resistance-trained men.” Nutrition & metabolism vol. 10,1 57. 22 Sep. 2013, doi:10.1186/1743-7075-10-57; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849389/
  8. S.P. Hirsch, L.G. Huber, R.A. Stein, K. Schmid, A.G. Swick, S.V. Joyal; “A randomized, double-blind, placebo-controlled study comparing the healthy levels of blood sugar and endothelial function of PEAK ATP® with GlycoCarn®, PEAK ATP® and GlycoCarn® supplementation versus placebo (Abstract)”; FASEB Journal, 31 (1) (2017), p. 973.978; doi:10.1096/fasebj.31.1_supplement.973.8; https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fasebj.31.1_supplement.973.8
  9. Long, Gong, and Guo Qiang Zhang. “Effects of Adenosine Triphosphate (ATP) on Early Recovery after Total Knee Arthroplasty (TKA): A Randomized, Double-Blind, Controlled Study.” The Journal of Arthroplasty, vol. 29, no. 12, Dec. 2014, pp. 2347–2351, 10.1016/j.arth.2014.03.025; https://www.arthroplastyjournal.org/article/S0883-5403(14)00197-1/fulltext
  10. ‌Freitas MC, Cholewa JM, Gerosa-Neto J, Gonçalves DC, Caperuto EC, Lira FS, Rossi FE. A Single Dose of Oral ATP Supplementation Improves Performance and Physiological Response During Lower Body Resistance Exercise in Recreational Resistance-Trained Males. J Strength Cond Res. 2019 Dec;33(12):3345-3352. doi: 10.1519/JSC.0000000000002198; https://journals.lww.com/nsca-jscr/Abstract/2019/12000/A_Single_Dose_of_Oral_ATP_Supplementation_Improves.18.aspx
  11. Moon, Jessica, et al. “Evaluating the Effects of PeakATP® Supplementation on Visuomotor Reaction Time and Cognitive Function Following High-Intensity Sprint Exercise.” Frontiers in Nutrition, vol. 10, 4 Aug. 2023; https://www.frontiersin.org/articles/10.3389/fnut.2023.1237678/full
  12. González-Marenco, Roberto, et al. “The Effect of Oral Adenosine Triphosphate (ATP) Supplementation on Anaerobic Exercise in Healthy Resistance-Trained Individuals: A Systematic Review and Meta-Analysis.” Sports, vol. 12, no. 3, 1 Mar. 2024, p. 82, doi:10.3390/sports12030082. https://www.mdpi.com/2075-4663/12/3/82
  13. ‌Jäger, Ralf, et al. “Oral Adenosine-5′-Triphosphate (ATP) Administration Increases Blood Flow Following Exercise in Animals and Humans.” Journal of the International Society of Sports Nutrition, vol. 11, no. 1, 2014, p. 28, 10.1186/1550-2783-11-28; https://jissn.biomedcentral.com/articles/10.1186/1550-2783-11-28
  14. Lelo, A., et al. “Comparative Pharmacokinetics of Caffeine and Its Primary Demethylated Metabolites Paraxanthine, Theobromine and Theophylline in Man.” British Journal of Clinical Pharmacology, vol. 22, no. 2, Aug. 1986, pp. 177–182, doi:10.1111/j.1365-2125.1986.tb05246.x. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1401099/pdf/brjclinpharm00125-0054.pdf
  15. Guerreiro, Serge, et al. “Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels.” Molecular Pharmacology, vol. 74, no. 4, 11 July 2008, pp. 980–989, doi:10.1124/mol.108.048207. https://molpharm.aspetjournals.org/content/74/4/980
  16. Arnaud, M. J., and C. Welsch. “Theophylline and Caffeine Metabolism in Man.” Theophylline and Other Methylxanthines / Theophyllin Und Andere Methylxanthine, 1982, pp. 135–148, doi:10.1007/978-3-663-05268-5_18. https://link.springer.com/chapter/10.1007/978-3-663-05268-5_18
  17. Gkouskou, Kalliopi G., et al. “CYP1A2 Polymorphisms Modify the Association of Habitual Coffee Consumption with Appetite, Macronutrient Intake, and Body Mass Index: Results from an Observational Cohort and a Cross-over Randomized Study.” International Journal of Obesity, vol. 46, no. 1, 1 Jan. 2022, pp. 162–168, doi:10.1038/s41366-021-00972-6; https://pubmed.ncbi.nlm.nih.gov/34564706/
  18. dePaula, Juliana, and Adriana Farah. “Caffeine Consumption through Coffee: Content in the Beverage, Metabolism, Health Benefits and Risks.” Beverages, vol. 5, no. 2, 1 June 2019, p. 37, doi:10.3390/beverages5020037; https://www.mdpi.com/2306-5710/5/2/37/htm
  19. Guessous, Idris, et al. “Associations of Ambulatory Blood Pressure with Urinary Caffeine and Caffeine Metabolite Excretions.” Hypertension, vol. 65, no. 3, Mar. 2015, pp. 691–696, doi:10.1161/hypertensionaha.114.04512; https://pubmed.ncbi.nlm.nih.gov/25489060/
  20. Nehlig, Astrid. “Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption.” Pharmacological Reviews, vol. 70, no. 2, 7 Mar. 2018, pp. 384–411, 10.1124/pr.117.014407; https://pubmed.ncbi.nlm.nih.gov/29514871/
  21. Ngueta, Gerard. “Caffeine and caffeine metabolites in relation to hypertension in U.S. adults.” European journal of clinical nutrition vol. 74,1 (2020): 77-86. doi:10.1038/s41430-019-0430-0 https://www.nature.com/articles/s41430-019-0430-0
  22. Arnaud, Maurice J. “Pharmacokinetics and metabolism of natural methylxanthines in animal and man.” Handbook of experimental pharmacology, 200 (2011): 33-91. doi:10.1007/978-3-642-13443-2_3 https://link.springer.com/chapter/10.1007/978-3-642-13443-2_3
  23. Orrú, Marco, et al. “Psychostimulant Pharmacological Profile of Paraxanthine, the Main Metabolite of Caffeine in Humans.” Neuropharmacology, vol. 67C, 1 Apr. 2013, pp. 476–484, doi:10.1016/j.neuropharm.2012.11.029. https://www.sciencedirect.com/science/article/abs/pii/S002839081200576X
  24. Chou, Chi-Chung, and Thomas W. Vickroy. “Antagonism of Adenosine Receptors by Caffeine and Caffeine Metabolites in Equine Forebrain Tissues.” American Journal of Veterinary Research, vol. 64, no. 2, Feb. 2003, pp. 216–224, doi:10.2460/ajvr.2003.64.216. https://pubmed.ncbi.nlm.nih.gov/12602592/ (full-text PDF)
  25. Ferré, Sergi, et al. “Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission.” Journal of Caffeine Research, vol. 3, no. 2, June 2013, pp. 72–78, doi:10.1089/jcr.2013.0006. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680978/
  26. Orrú, Marco, et al. “Psychostimulant Pharmacological Profile of Paraxanthine, the Main Metabolite of Caffeine in Humans.” Neuropharmacology, vol. 67C, 1 Apr. 2013, pp. 476–484, doi:10.1016/j.neuropharm.2012.11.029. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562388/
  27. Guerreiro, Serge, et al. “Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels.” Molecular Pharmacology, vol. 74, no. 4, 11 July 2008, pp. 980–989, doi:10.1124/mol.108.048207. https://pubmed.ncbi.nlm.nih.gov/18621927/
  28. Benowitz, Neal L., et al. “Sympathomimetic Effects of Paraxanthine and Caffeine in Humans*.” Clinical Pharmacology & Therapeutics, vol. 58, no. 6, Dec. 1995, pp. 684–691, doi:10.1016/0009-9236(95)90025-x; https://pubmed.ncbi.nlm.nih.gov/8529334/
  29. Yoo, Choongsung et al. “Acute Paraxanthine Ingestion Improves Cognition and Short-Term Memory and Helps Sustain Attention in a Double-Blind, Placebo-Controlled, Crossover Trial.” Nutrients vol. 13,11 3980. 9 Nov. 2021, doi:10.3390/nu13113980; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622427/
  30. Hetzler, R. K., et al. “Effect of Paraxanthine on FFA Mobilization after Intravenous Caffeine Administration in Humans.” Journal of Applied Physiology (Bethesda, Md.: 1985), vol. 68, no. 1, 1 Jan. 1990, pp. 44–47, doi:10.1152/jappl.1990.68.1.44; https://pubmed.ncbi.nlm.nih.gov/2312486/
  31. Gross, Kristen N et al. “A Dose-Response Study to Examine Paraxanthine’s Impact on Energy Expenditure, Hunger, Appetite, and Lipolysis.” Journal of dietary supplements, 1-25. 14 May. 2024, doi:10.1080/19390211.2024.2351222. https://www.tandfonline.com/doi/full/10.1080/19390211.2024.2351222
  32. Horrigan, L, et al. “Immunomodulatory Effects of Caffeine: Friend or Foe?” Pharmacology & Therapeutics, vol. 111, no. 3, Sept. 2006, pp. 877–892, doi:10.1016/j.pharmthera.2006.02.002. https://pubmed.ncbi.nlm.nih.gov/16540173/

Comments and Discussion (Powered by the PricePlow Forum)